Globus Medical

YTD

ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Globus Medical and other ETFs, options, and stocks.

About GMED

Globus Medical, Inc. operates as a medical device company that develops and commercializes healthcare solutions. It engages in developing products that promote healing in patients with musculoskeletal disorders.

CEO

Keith W. Pfeil

CEOKeith W. Pfeil

Employees

6,000

Employees6,000

Headquarters

Audubon, Pennsylvania

HeadquartersAudubon, Pennsylvania

Founded

2003

Founded2003

Employees

6,000

Employees6,000

GMED Key Statistics

Market cap

10.86B

Market cap10.86B

Price-Earnings ratio

18.75

Price-Earnings ratio18.75

Dividend yield

—

Dividend yield—

Average volume

1.64M

Average volume1.64M

High today

$80.70

High today$80.70

Low today

$79.84

Low today$79.84

Open price

$80.60

Open price$80.60

Volume

389.25K

Volume389.25K

52 Week high

$101.40

52 Week high$101.40

52 Week low

$51.79

52 Week low$51.79

Stock Snapshot

The current Globus Medical(GMED) stock price is $80.03, with a market capitalization of 10.86B. The stock trades at a price-to-earnings (P/E) ratio of 18.75.

On 2026-06-12, Globus Medical(GMED) stock traded between a low of $79.84 and a high of $80.70. Shares are currently priced at $80.03, which is +0.2% above the low and -0.8% below the high.

Globus Medical(GMED) shares are trading with a volume of 389.25K, against a daily average of 1.64M.

During the past year, Globus Medical(GMED) stock moved between $51.79 at its lowest and $101.40 at its peak.

GMED News

Simply Wall St 14h

What Globus Medical's Upgraded Earnings Outlook and Rising ROIC Concerns Mean For Shareholders

In early June 2026, Globus Medical reported a strong first quarter with 27% overall revenue growth, record earnings, and reaffirmed full‑year revenue guidance w...

TipRanks 3d

Major Insider Move at Globus Medical Sparks Investor Buzz

New insider activity at Globus Medical ( (GMED) ) has taken place on June 9, 2026. Introducing TipRanks MCP for Agents Deliver institutional-grade market data d...

Nasdaq 3d

Here's How GMED Is Capitalizing on the Musculoskeletal Market Boom

According to a report by Market Research Intellect, the musculoskeletal system market was valued at $15.6 billion in 2025 and is projected to witness a CAGR of...

Analyst ratings

67%

of 15 ratings

Buy

66.7%

Hold

33.3%

Sell

More GMED News

Nasdaq 3d

Should You Add Myriad Genetics Stock to Your Portfolio Right Now?

Myriad Genetics, Inc. MYGN is well poised for growth in the coming quarters due to its impressive cadence of product launches. It is also poised to capitalize o...

People also own

Based on the portfolios of people who own GMED. This list is generated using Robinhood data, and it’s not a recommendation.

Shopify

CrowdStrike Holdings

Trade Desk

Take-Two Interactive Soft…

Airbnb

Unity Software

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.